Mirae Asset Global Investments Co., Ltd. Vanda Pharmaceuticals Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

$28 Billion
Q2 2025

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,277 shares of VNDA stock, worth $9,813. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,277

Previous 1,951 16.71%

Holding current value

$9,813

Previous $8,000 25.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 21, 2025	BUY	$3.92 - $4.82 $1,277 - $1,571	326 Added 16.71%	2,277 $10,000
Q1 2025 Apr 24, 2025	BUY	$4.31 - $5.13 $34 - $41	8 Added 0.41%	1,951 $8,000
Q4 2024 Jan 27, 2025	SELL	$4.41 - $5.46 $727 - $900	-165 Reduced 7.83%	1,943 $9,000
Q3 2024 Oct 23, 2024	BUY	$4.61 - $6.34 $1,705 - $2,345	370 Added 21.29%	2,108 $9,000
Q2 2024 Jul 30, 2024	SELL	$3.91 - $6.5 $102,168 - $169,845	-26,130 Reduced 93.76%	1,738 $9,000
Q1 2024 May 01, 2024	BUY	$3.47 - $4.61 $943 - $1,253	272 Added 0.99%	27,868 $114,000
Q4 2023 Jan 24, 2024	BUY	$3.38 - $4.58 $287 - $389	85 Added 0.31%	27,596 $116,000
Q3 2023 Oct 26, 2023	SELL	$4.28 - $6.57 $31,988 - $49,104	-7,474 Reduced 21.36%	27,511 $118,000
Q2 2023 Aug 10, 2023	SELL	$5.9 - $6.95 $7,616 - $8,972	-1,291 Reduced 3.56%	34,985 $230,000
Q1 2023 May 04, 2023	BUY	$6.18 - $7.99 $53,667 - $69,385	8,684 Added 31.47%	36,276 $246,000
Q4 2022 Feb 09, 2023	BUY	$6.87 - $10.96 $23,179 - $36,979	3,374 Added 13.93%	27,592 $203,000
Q3 2022 Nov 10, 2022	BUY	$9.44 - $11.76 $67,127 - $83,625	7,111 Added 41.57%	24,218 $239,000
Q2 2022 Jul 26, 2022	BUY	$9.31 - $11.84 $159,266 - $202,546	17,107 New	17,107 $187,000

Others Institutions Holding VNDA

# of Institutions

159

Shares Held

44.4M

Call Options Held

49.4K

Put Options Held

562K

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $244M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Account

Mirae Asset Global Investments Co., Ltd. Vanda Pharmaceuticals Inc. Transaction History